StockTake: EBR ready to WISE-UP as cardiac pacing study signs first patients
Host Tylah Tully looks at EBR Systems (ASX:EBR) latest news, as the company enrols its first patients in a key study to evaluate the effectiveness of its ground-breaking WISE EBR device.
The first two patients in the WISE-UP post-approval study were treated at St Bernards Heart and Vascular Centre in Arkansas by leading global electro-physiologist Dr Devi Nair.
Watch the video to hear the details.
This video was developed in collaboration with EBR Systems, a Stockhead client at the time of publishing.
The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
Related Topics
UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.